<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02322424</url>
  </required_header>
  <id_info>
    <org_study_id>Japan-Taiwan PD Project</org_study_id>
    <nct_id>NCT02322424</nct_id>
  </id_info>
  <brief_title>Predictive Risk Factors for Pancreatic Fistula Grade C After Pancreaticoduodenectomy</brief_title>
  <official_title>Predictive Risk Factors for Pancreatic Fistula Grade C After Pancreaticoduodenectomy: Prospective Large Observational Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wakayama Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wakayama Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Pancreatic fistula (PF) grade C, defined by the International Study Group of Pancreatic
      Fistula (ISGPF) is associated with a life-threatening complication after
      pancreaticoduodenectomy(PD). Therefore, The aim of this study is to clarify the risk factors
      for grade C PF by Japan and Taiwan cooperative project.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pancreatic fistula (PF) grade C, defined by the International Study Group of Pancreatic
      Fistula (ISGPF) is associated with a life-threatening complication after
      pancreaticoduodenectomy(PD). The rate of grade C PF has been reported 2.5-6%, however, it is
      critical complication after PD. A large number of enrolled patients will be needed to clarify
      the risk factors for grade C PF. Therefore, this study design is prospective large
      observational study at multi-center in Japan and Taiwan.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2014</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>42 Months</target_duration>
  <primary_outcome>
    <measure>Incidence of pancreatic fistula grade C</measure>
    <time_frame>90 days after pancreaticoduodenectomy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Incidence of overall pancreatic fistula (grade A, grade B and grade C)</measure>
    <time_frame>90 days after pancreaticoduodenectomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of clinical relevant pancreatic fistula (grade B and grade C)</measure>
    <time_frame>90 days after pancreaticoduodenectomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of postpancreatecomy hemorrhage(PPH)</measure>
    <time_frame>90 days after pancreaticoduodenectomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cut-off value of drain amylase fluid on POD1 to distinguish pancreatic fistula grade C with grade A and grade B</measure>
    <time_frame>90 days after pancreaticoduodenectomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cut-off value of drain amylase fluid on POD1 to distinguish pancreatic fistula grade B and C with grade A</measure>
    <time_frame>90 days after pancreaticoduodenectomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>90 days after pancreaticoduodenectomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day mortality</measure>
    <time_frame>30 days after pancreaticoduodenectomy</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>90-day mortality</measure>
    <time_frame>90 days after pancreaticoduodenectomy</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Disease of Pancreatic Head or Periampullary Lesions to Require Pancreaticoduodenectomy</condition>
  <arm_group>
    <arm_group_label>Patients who undergo pancreaticoduodenectomy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>pancreaticoduodenectomy</intervention_name>
    <arm_group_label>Patients who undergo pancreaticoduodenectomy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        3,000 patients who undergo pancreaticoduodenectomy (PD) in Japan and Taiwan
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Disease of pancreatic head or periampullary lesions to require pancreaticoduodenectomy

          2. Age: 20 years or older

          3. PS (ECOG performance status scale) 0-1 at the time of enrollment

          4. Ability to understand and the willingness to sign a written informed consent document

        Exclusion Criteria:

          1. patients with severe respiratory disorder required oxygen inhalation

          2. patients with severe liver dysfunction

          3. patients with chronic renal failure with dialysis

          4. patients who are unfit for this study as determined by the attending physician
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hiroki Yamaue, M.D., PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wakayama Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hiroki Yamaue, M.D., PhD.</last_name>
    <phone>+81-73-441-0613</phone>
    <email>yamaue-h@wakayama-med.ac.jp</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Hiroki Yamaue, M.D., PhD.</last_name>
    <phone>+81-73-441-0613</phone>
    <email>trial-jt@wakayama-med.ac.jp</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Chang Gun Memorial Hospital</name>
      <address>
        <city>Linkou</city>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tsann-Long Hwang, M.D., PhD.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 17, 2014</study_first_submitted>
  <study_first_submitted_qc>December 17, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 23, 2014</study_first_posted>
  <last_update_submitted>December 17, 2014</last_update_submitted>
  <last_update_submitted_qc>December 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 23, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Wakayama Medical University</investigator_affiliation>
    <investigator_full_name>Hiroki Yamaue</investigator_full_name>
    <investigator_title>Second Department of Surgery</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fistula</mesh_term>
    <mesh_term>Pancreatic Fistula</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

